Colon specific delivery of budesonide based on triple coated pellets: in vitro/in vivo evaluation.
Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P.
Varshosaz J, et al.
Acta Pharm. 2012 Nov;62(3):341-56. doi: 10.2478/v10007-012-0025-y.
Acta Pharm. 2012.
PMID: 23470347
Free article.
Pellet core composition and type and level of pore former affected the drug release from pellets. Pellets containing 20% (m/m) citric acid in the cores coated with HPMC at a coating level of 6% (m/m), Eudragit E containing Avicel RC 581 (30%) as pore f …
Pellet core composition and type and level of pore former affected the drug release from pellets. Pellets containing 20% (m/m) …